INTRODUCTION
The transcription factor NF-KB comprises a multicomponent protein complex that plays a major role in the regulation of many viral and cellular genes. First described as an 11-bp &s-acting sequence in the immunoglobulin light-chain enhancer (Sen and Baltimore, 1986a) , related sites have been described in a variety of other genes, including viral (Nabel and Baltimore, 1987; Boshart et al., 1985) and other cellular genes (Leung and Nabel, 1988; Bohnlein et al., 1988; Ruben et al., 1988; Israel et al., 1989; Lenardo and Baltimore, 1989) . Many of these cellular target genes of NF-KB are involved in the regulation of immunological functions. NF-KB activity is constitutively present in mature B cells (Sen and Baltimore, 1986a) and macrophages (Griffin et al., 1989) and can be activated in T cells and nonlymphoid cells by endogenous and exogenous stimuli (Sen and Baltimore, 1986b; Nabel and Baltimore, 1987; Griffin et al., 1989; Osborn et al., 1989) . The active NF-KB complex is formed in the cytoplasm after the dissociation of an inhibitory protein, IKB, and consists of a 50-kDa and a 65-kDa subunit which are translocated to the nucleus (Baeuerle and Baltimore, 1988a,b) .
Recently NF-KB genes have been isolated and found to be related to the maternal effect gene dorsal and to the oncogene c-rel (Kieran et al., 1990; Ghosh et al., 1990; Bours et al., 1990; Schmid et al., 1991; Ruben et al., 1991; Ryseck et al., 1992) . One 50-kDa DNA binding subunit was presumed to be synthesized from a 105-kDa precursor which would require proteolytic processing (Kieran et al., 1990; Ghosh et al., 1990 ). An alternative DNA binding subunit can also be generated in the same way from a second independent gene product of 100 kDa or as an alternatively spliced form of this gene (Schmid et al., 1991) . ~100 and ~105 are highly homologous in both N and C termini. Another subfamily is defined by c-rel and p65 (Schmid et al., 1991) , which contain putative transactivation domains at their C termini. Alignment of their sequences reveals highly conserved subregions, which are thought to participate in DNA binding and dimerization. So far, five independent cDNAs that encode gene products related to the NF-KB complex have been cloned, giving rise to a multigene family (Schmid et al., 1991) . Among the members of the NF-KB/rel/dorsal family, only the human c-rel gene has been previously localized, to chromosome 2~12-2~13 (Brownell et al., 1988) . To investigate the relationship between NF-KB p49/plOO, NF-KB ~105, and c-rel further, and to analyze the possible correlation to pathological conditions, the chromosomal localization of p49/plOO and ~105 was determined. Isolation of full-length ~105 and p49/plOO cDNAs has been described previously (Schmid et al., 1991) .
MATERIALS

Somatic cell hybrids.
Chromosomal localization of p49/plOO was carried out by Southern blot analysis of a panel of 24 human/Chinese hamster cell hybrids ( Fig. 1) . Each of the hybrids used contains from one to three human chromosomes and collectively allow assignment of a marker to any one of the 24 distinct human chromosomes (Scherer et al., 1992) . The chromosomes retained by each of the cell hybrids are shown in Fig. 1 . The probe used in the mapping experiment was the whole cDNA clone of p49 described previously (Schmid et al., 1991 
RESULTS
Isolation of Human Genomic p49jplOO and ~105
Probes prepared from cDNAs encoding the NF-KB subunits p49/plOO and ~105 were used to screen human genomic libraries at high stringency. A total of seven clones for p49/plOO and eight clones for ~105 were isolated and plaque purified. Several clones were characterized by restriction enzyme mapping, Southern blotting, and DNA sequence analysis. The phage insert sizes ranged between 14 and 20 kb. A clone of p49/plOO containing an approximately 15kb insert, plOO.G25, and a ~105 clone with an approximately 20-kb insert, p105.G2, were used for FISH, respectively. Chromosomal Assignment of p49/plOO Using Somatic Cell Hybrids Figure 1 shows the assignment of p49/plOO to chromosome 10. In addition to total human DNA (lane 26), human-specific hybridization of the p49/plOO probe was observed only to DNA from the hybrid cell line HHW983. This cell line contains only human chromosomes 5 and 10 in addition to the Chinese hamster genome. Since DNA from cell line HHW105 (lane 6) and all other hybrids which contain a human chromosome 5 clearly do not show human-specific hybridization to the p49/plOO probe, this locus has been assigned to human chromosome 10.
Chromosomal Localization of p49/plOO by Fluorescence in Situ Hybridization
A genomic p49/plOO clone, plOO.G25 was localized to human metaphase chromosomes by FISH analysis. Twenty-five cells were examined. Fluorescence hybridization signals were observed in 13 cells (52%). Of the hybridization signals observed, 97% localized specifically to chromosome 10. Fluorescence signals were observed on both homologs of chromosome 10 in B/13 cells, and in 5/13 cells, only one homolog gave a signal for a total of 21 chromosomes analyzed. Of these 21 chromosomes, the majority demonstrated hybridization to both chromatids (38/42 chromatids). The procedure utilized allowed for G-banding of the same mitoses used for FISH analysis, permitting unequivocal localization of fluorescent signals. All 38 of the specific hybridization signals observed localized to the band lOq24 ( Figs. 2A  and B ).
Chromosomal Assignment of ~105 Using Somatic Cell Hybrids
Southern blot analysis of a human chromosome mapping panel (Tabas et al., 1991 ) using a fragment of the ~105 cDNA as a probe revealed 100% concordance between human chromosome 4 and a specific Hind111 restriction fragment detected by the probe (data not shown). This result was confirmed and the gene encoding ~105 was regionally localized on chromosome 4 by similar analysis of a panel of seven additional cell hybrids which retain specific segments of chromosome 4. These results are summarized in Fig. 3 ization to both chromatids (47 of 50 chromatids). By comparison to the previously G-banded photographs, this specific hybridization was located to chromosome 4q23 (Figs. 2C and D) .
DISCUSSION
In this study, we have determined the chromosomal locations of the human genes NFKBl and NFKBB which encode the two alternative DNA binding subunits of NF-KB, ~105 and p49/plOO. ~105 was assigned to chromosome 4q21.1-q24 and p49/plOO to chromosome 10 by Southern blot analysis of panels of human/Chinese hamster cell hybrids with probes generated from cDNAs. The locations were confirmed by fluorescence in. situ hybridization using genomic phage clones and mapped with greater resolution to 4q23 and lOq24, respectively. Human c-rel has been previously localized to chromosome 2~12-2~13 by translocation chromosome analysis (Brownell et al., 1988) . Taken Five independent human cDNAs have been isolated which encode gene products of the NF-KB/rel family. A consensus sequence of conserved amino acids within different domains is evident. The amino-terminal domain which has been shown to confer DNA binding and dimerization is found in p49/plOO, ~105, ~65, and c-rel. ~100 and ~105 are most similar to one another, with 52% identity compared to conserved amino acids of all family members (26% identity) in this region.
Though the genes for the human members of the NF-KB/rel/dorsal family appear to be dispersed throughout the genome, evidence is accumulating that this family may have descended from a common ancestor gene.
Comparison of the family members on the nucleotide level shows highly conserved regions within different domains. In the presumed DNA binding and dimerization domain, p49/plOO and ~105 are 66% identical at the DNA level, whereas comparing this domain with all family members results only in 25% identity.
Nonrandom chromosomal abnormalities have been identified in a variety of leukemias, lymphomas, and other malignancies. In acute lymphoblastic leukemia (ALL), the most frequent chromosomal and structural alterations include t(8;14), t(9;22), t(4;11), 14q+, 6q-, t(11;14), and t(10;14) (Botti and Verma, 1990) . Genes located near or within these breakpoints are thought to be pathogenically involved in the alteration of growth and differentiation. Although the c-rel gene is associated with malignant transformation in avian species, the role of NF-KB gene products in malignancy is unknown. The translocation t(4;ll) (q21;q23) has recently been observed in 8.3% of patients with ALL (Third International Workshop on Chromosomes in Leukemia, 1981) , especially those with congenital leukemia (Prigogina et al., 1979; Arthur et al., 1982) . A cell line containing this translocation showed that the cells contain rearranged immunoglobin heavyand light (K)-chain genes, providing evidence for B-cell differentiation. However, these cells tested negative for cytoplasmic immunoglobulins (Stong et al., 1985) . Since NF-KB is a major transcription factor involved in immunoglobin light-chain expression, genetic changes causing alterations of NF-KB activity might contribute to this phenotype. Approximately 7% of T-cell ALLs contain the t(10;14) (q24;qll) translocation (Dube et al., 1986; Raimondi et al., 1988) . Rearrangements of the Tcell-receptor 6 chain on chromosome 14qll were used to clone breakpoints within chromosome lOq24. Recently, a homeodomain containing gene HOX 11 has been suggested as a candidate gene undergoing deregulation in t(10;14) (Hatano et al., 1991; Lu et al., 1991) . Since different breakpoints have been observed in a fragile site at lOq24 (Kagan et al., 1989; Boehm et al., 1989; Zutter et al., 1990; Lu et al., 1990) near the site of p49/plOO NF-KB, it remains to be determined whether HOX 11 is the only gene involved in this translocation. Further studies of cells containing these specific chromosome 4 or 10 translocations will determine whether NF-KB plays a causal role in human malignancy.
